We are live on ! Find out more
BFO

Boston Family Office Portfolio holdings

AUM $1.5B
1-Year Est. Return 11.68%
This Fund
S&P 500
This Quarter Est. Return
+6.37%
1 Year Est. Return
+11.68%
3 Year Est. Return
+44.44%
5 Year Est. Return
+55.04%
10 Year Est. Return
+251.5%
AUM
$813M
AUM Growth
+$43.5M
Cap. Flow
-$1.72M
Cap. Flow %
-0.21%
Top 10 Hldgs %
20.71%
Holding
251
New
10
Increased
63
Reduced
107
Closed
7

Top Buys

Rank Stock Value
1
ADP icon
Automatic Data Processing
ADP
+$2.9M
2
AL
Air Lease Corp
AL
+$2.05M
3
IQV icon
IQVIA
IQV
+$1.92M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.89M
5
GE icon
GE Aerospace
GE
+$1.74M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$2.64M
2
MIDD icon
Middleby
MIDD
+$2.44M
3
GILD icon
Gilead Sciences
GILD
+$1.58M
4
ROK icon
Rockwell Automation
ROK
+$1.34M
5
AAPL icon
Apple
AAPL
+$1.04M

Sector Composition

Rank Sector Weight
1 Healthcare 17.01%
2 Industrials 14.02%
3 Technology 13.29%
4 Consumer Staples 10.45%
5 Financials 7.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NSC icon
101
Norfolk Southern
NSC
$76.7B
$2.1M 0.26%
18,753
– –
AXP icon
102
American Express
AXP
$234B
$2.02M 0.25%
25,558
-75
-0.3% -$5.86K
GLW icon
103
Corning
GLW
$137B
$1.99M 0.24%
73,512
-3,225
-4% -$85.8K
VEA icon
104
Vanguard FTSE Developed Markets ETF
VEA
$234B
$1.95M 0.24%
49,730
-1,305
-3% -$50K
APC
105
DELISTED
Anadarko Petroleum
APC
$1.85M 0.23%
29,838
+375
+1% +$25K
CMCSA icon
106
Comcast
CMCSA
$88.5B
$1.84M 0.23%
49,080
+400
+0.8% +$14.8K
SSNC icon
107
SS&C Technologies
SSNC
$19B
$1.81M 0.22%
51,015
-630
-1% -$21.2K
GOOGL icon
108
Alphabet (Google) Class A
GOOGL
$4.62T
$1.79M 0.22%
42,320
+2,920
+7% +$123K
RTX icon
109
RTX Corp
RTX
$294B
$1.79M 0.22%
25,384
-2,015
-7% -$141K
NVO
110
Novo Nordisk
NVO
$196B
$1.77M 0.22%
103,260
+1,500
+1% +$26.1K
NTRS icon
111
Northern Trust
NTRS
$33.4B
$1.77M 0.22%
20,434
+775
+4% +$67.4K
CPB icon
112
Campbell Soup
CPB
$6.79B
$1.75M 0.21%
30,545
+1,025
+3% +$62K
K
113
DELISTED
Kellanova
K
$1.74M 0.21%
25,480
– –
QCOM icon
114
Qualcomm
QCOM
$171B
$1.72M 0.21%
30,073
-1,275
-4% -$74K
META icon
115
Meta Platforms (Facebook)
META
$1.5T
$1.72M 0.21%
12,121
+25
+0.2% +$3.34K
ITW icon
116
Illinois Tool Works
ITW
$84.9B
$1.71M 0.21%
12,938
-15
-0.1% -$1.94K
DEO icon
117
Diageo
DEO
$48.8B
$1.71M 0.21%
14,772
+97
+0.7% +$10.9K
MDLZ icon
118
Mondelez International
MDLZ
$79.2B
$1.7M 0.21%
39,420
-350
-0.9% -$15.5K
WFC icon
119
Wells Fargo
WFC
$267B
$1.63M 0.2%
29,282
-3,098
-10% -$176K
HUBB icon
120
Hubbell
HUBB
$26.5B
$1.59M 0.2%
13,250
– –
BDX icon
121
Becton Dickinson
BDX
$46.9B
$1.57M 0.19%
8,780
-98
-1% -$17.1K
KMB icon
122
Kimberly-Clark
KMB
$37B
$1.51M 0.19%
11,498
– –
NWL icon
123
Newell Brands
NWL
$2.61B
$1.49M 0.18%
31,545
+1,180
+4% +$56K
IFF icon
124
International Flavors & Fragrances
IFF
$20.7B
$1.47M 0.18%
11,065
+775
+8% +$95.2K
AGN
125
DELISTED
Allergan plc
AGN
$1.45M 0.18%
6,052
-490
-7% -$114K
3 4
5
6 7

Similar funds

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
JFGLC
Johnson Financial Group LLC (Colorado) Denver, Colorado $1.5B AUM 16.09% 1-Year Est. Return
AAM
Aureus Asset Management Boston, Massachusetts $1.5B AUM 20.3% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
SCM
SG Capital Management Chicago, Illinois $1.51B AUM 49.98% 1-Year Est. Return
FMI
F/M Investments Washington, District of Columbia $1.51B AUM 25.86% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
RCW
Rheos Capital Works Tokyo, Japan $1.5B AUM 47.78% 1-Year Est. Return

Boston Family Office's Q1 2017 Portfolio in Review

As of Q1 2017, Boston Family Office held 251 positions worth $813M, up 5.6% from $770M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Boston Family Office's Q1 2017 filing shows 10 new, 63 increased, 107 reduced and 7 closed positions. Its largest new stake was Teradyne: 22,100 shares worth $687K. The largest sale was Teva Pharmaceuticals, an estimated $2.64M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 17% a quarter earlier, followed by Industrials and Technology.

  • Boston Family Office's largest Q1 2017 buy was Teradyne: 22,100 shares worth $687K.
  • Boston Family Office added most to Automatic Data Processing in Q1 2017, an estimated $2.9M increase.
  • Boston Family Office's biggest Q1 2017 reduction was Middleby, cutting an estimated $2.44M.
  • Boston Family Office fully exited Teva Pharmaceuticals in Q1 2017, selling an estimated $2.64M.
  • Boston Family Office's ten largest holdings make up 21% of its $813M portfolio in Q1 2017.
  • Boston Family Office opened 10 new positions and closed 7 in Q1 2017.
  • Boston Family Office's portfolio value rose 5.6% quarter-over-quarter to $813M.

Based on Boston Family Office's 13F filing for Q1 2017, filed 5 May 2017.